| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9311708 | Urology | 2005 | 5 Pages |
Abstract
Our findings suggest that a well-defined subset of patients undergoing RCx might be at low risk for malignancy in the prostate. However, further evaluation of these risk factors in a prospective setting will be required to substantiate these findings and guide clinical decision making in this controversial field.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
John C. Kefer, Bryan B. Voelzke, Robert C. Flanigan, Eva M. Wojcik, W. Bedford Waters, Steven C. Campbell,